Fundz

RLS APPOINTS GLENN SULLIVAN AS DIRECTOR OF REGULATORY AFFAIRS

PRIVATEJun 13, 2023

Position

Director

Company

RLS Radiopharmacies

Glenn Sullivan
glenn.sullivan@rls.bio
United StatesManufacturingBiotechnologyHealth Care

Description

Today, RLS , Inc. , the third-largest nuclear pharmacy network in the US, announced the appointment of Glenn Sullivan as Director of Regulatory Affairs. Sullivan, a 25-year veteran of the radiopharmacy and healthcare industry, will help ensure RLS continues to meet the highest bar for regulatory compliance on the local, state and federal levels as the radiopharmacy network continues to expand.","As Director of Regulatory Affairs, Sullivan will drive local, state and federal regulatory strategy for the company, ensuring RLS continues to meet the highest standards in regulatory compliance as the only Joint Commission accredited radiopharmacy network in the country

Quick answer

RLS APPOINTS GLENN SULLIVAN AS DIRECTOR OF REGULATORY AFFAIRS (June 13, 2023). RLS Radiopharmacies is based in United States.

Who is the new Director at RLS Radiopharmacies?
RLS Radiopharmacies named Glenn Sullivan Director, announced June 13, 2023.
What did RLS Radiopharmacies announce on June 13, 2023?
Today, RLS , Inc. , the third-largest nuclear pharmacy network in the US, announced the appointment of Glenn Sullivan as Director of Regulatory Affairs.
What does RLS Radiopharmacies do?
RLS Radiopharmacies is a provider of radiopharmaceuticals for medical use, emphasizing on delivering high-quality products in the healthcare sector.
Where is RLS Radiopharmacies based?
RLS Radiopharmacies is based in United States.
Which similar companies made leadership changes around the same time?
Precision Optics Corporation (June 12, 2023), Amarna Therapeutics (June 7, 2023), Piramal Critical Care (June 6, 2023) and Catalent Pharma Solutions (June 20, 2023) also announced leadership changes within 45 days of RLS Radiopharmacies.

Source: Fundz verified event record.

Other recent leadership changes in Manufacturing and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at RLS Radiopharmacies, and when

A new leader at RLS Radiopharmacies brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day RLS Radiopharmacies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at RLS Radiopharmacies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at RLS Radiopharmacies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

RLS Radiopharmacies

Location

United States

About

RLS Radiopharmacies is a provider of radiopharmaceuticals for medical use, emphasizing on delivering high-quality products in the healthcare sector. The company has been involved in providing essential services to the oncology community. Their acquisition by Telix Pharmaceuticals enhances Telix's operational capacity and market reach. RLS is pivotal for expanding Telix's manufacturing footprint in the U.S.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment RLS Radiopharmacies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Glenn
Likely contact at this company
••••••••@••••••••

See Glenn's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for RLS Radiopharmacies's next move

Learn about Strategic plan

RLS Radiopharmacies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.